Enfuvirtide administration in HIV-positive transgender patient with soft tissue augmentation: US evaluation

Eugenia Gabrielli, Giovanna Ferraioli, Laurenzia Ferraris, Agosfno Riva, Massimo Galii, Carlo Filice, Cristina Gervasoni

Research output: Contribution to journalArticle


Enfuvirtide is a large protein that should be injected subcutaneously to ensure an appropriate absorption. Here we report the case of a transgender HIV-positive patient receiving enfuvirtide with an individualized background regimen of antiretroviral drugs, who had previously undergone liquid silicone oil injections. We performed US scan to detect silicone-free areas for following enfuvirtide injections. US can be useful in the correct management of those patients with liquid silicone oil soft tissue augmentation who require subcutaneously injected drugs.

Original languageEnglish
Pages (from-to)263-265
Number of pages3
JournalNew Microbiologica
Issue number3
Publication statusPublished - Jul 2010



  • Enfuvirtide
  • Silicon oil
  • Ultrasound

ASJC Scopus subject areas

  • Microbiology (medical)
  • Medicine(all)

Cite this